Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education

UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...

Medscape Education

- PMLiVE

Lilly’s early Alzheimer’s disease treatment approved in the EU

Marketing authorisation follows positive late-stage trial results

- PMLiVE

GSK names Luke Miels as next CEO

Current CEO Dame Emma Walmsley will step down in December

- PMLiVE

Launch excellence: innovative thinking meets insightful strategy

‘True launch excellence demands bold innovation, deep market insight and flawless alignment across product, market and organisational execution’

- PMLiVE

Roche’s Lunsumio receives positive CHMP opinion for follicular lymphoma

The recommendation for the subcutaneous formulation follows encouraging trial data

- PMLiVE

University of Liverpool identifies new class of antibiotic in fight against AMR

The new antibiotic class targets two of the WHO’s ‘priority pathogens’

- PMLiVE

Biopharma 2030 challenge: scaling product launches without growing teams

‘83% of large biopharmas plan to manage more launches without expanding their commercial teams’

- PMLiVE

Ipsen’s tumour treatment receives MHRA marketing authorisation

This is the first approval in the UK for previously treated advanced neuroendocrine tumours

- PMLiVE

New National Commission launched to strengthen AI regulation

The Commission will unite healthcare leaders, regulators and technology experts to shape future AI governance

- PMLiVE

Will data and AI prove to be the game-changer that transforms launch excellence?

Investing in data analytics and AI tools can lead to smarter clinical trials and faster, more informed decisions

- PMLiVE

New survey: Europeans seek better health equity in breast cancer awareness

‘More than 558,000 new breast cancer cases are diagnosed annually and the disease claims around 145,000 lives each year’

- PMLiVE

Novartis announces new data supporting MS therapy Kesimpta

The latest trial results reinforce the drug's long-term efficacy and safety profile

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links